Ken Griffin Acrivon Therapeutics, Inc. Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,140,628 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,140,628
Previous 2,119,646 0.99%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
20,982 Added 0.99%
2,140,628 $0
Q2 2024

Aug 14, 2024
BUY
N/A
439,619 Added 26.17%
2,119,646 $0
Q1 2024

May 15, 2024
BUY
N/A
30,368 Added 1.84%
1,680,027 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-798 Reduced 0.05%
1,649,659 $0
Q3 2023

Nov 14, 2023
BUY
N/A
811 Added 0.05%
1,650,457 $0
Q2 2023

Aug 14, 2023
BUY
N/A
8,624 Added 0.53%
1,649,646 $0
Q1 2023

May 15, 2023
BUY
N/A
6,918 Added 0.42%
1,641,022 $0
Q4 2022

Feb 14, 2023
BUY
N/A
1,634,104 New
1,634,104 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email